long-acting injectable platform
AbbVie Secures Deal with Medincell for Long-Acting Injectable Platform, Valued up to $1.9 Billion
AbbVie, Medincell, Long-acting injectable platform, Biotechnology, Deal, $1.9 billion
Actionable Insights Powered by AI
AbbVie, Medincell, Long-acting injectable platform, Biotechnology, Deal, $1.9 billion